| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YRTPH.2009.09.017 |
| P698 | PubMed publication ID | 19796662 |
| P2093 | author name string | Susan A Colilla | |
| P2860 | cites work | Use of smokeless tobacco, cigarette smoking, and hypercholesterolemia | Q93534046 |
| Tobacco harm reduction: an alternative cessation strategy for inveterate smokers | Q21093267 | ||
| Snus use and other correlates of smoking cessation in the Swedish Twin Registry | Q24597926 | ||
| Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players | Q24674093 | ||
| Effect of smokeless tobacco (snus) on smoking and public health in Sweden | Q24678371 | ||
| European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health | Q24678392 | ||
| Switching to smokeless tobacco as a smoking cessation method: evidence from the 2000 National Health Interview Survey | Q27497403 | ||
| Hemodynamic and autonomic effects of smokeless tobacco in healthy young men | Q28239735 | ||
| Causal effects of smokeless tobacco on mortality in CPS-I and CPS-II? | Q82315782 | ||
| A long-term follow-up study on the natural course of snus-induced lesions among Swedish snus users | Q82522503 | ||
| Progression of oral snuff use among Finnish 13-16-year-old students and its relation to smoking behaviour | Q82887241 | ||
| Prevalence of DSM/ICD-defined nicotine dependence | Q28240573 | ||
| Lifetime consumption of alcoholic beverages, tea and coffee and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands | Q28282870 | ||
| Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers | Q28369584 | ||
| Should the health community promote smokeless tobacco (snus) as a harm reduction measure? | Q33289777 | ||
| Meta-analysis of the relation between European and American smokeless tobacco and oral cancer | Q33305721 | ||
| Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results? | Q33402818 | ||
| Nicotine replacement therapy, professional therapy, snuff use and tobacco smoking: a study of smoking cessation strategies in southern Sweden | Q33593395 | ||
| Paan without tobacco: an independent risk factor for oral cancer | Q33895356 | ||
| Cigarettes and oral snuff use in Sweden: Prevalence and transitions | Q34018813 | ||
| Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden | Q34224171 | ||
| Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. | Q34333924 | ||
| A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). | Q34343379 | ||
| Swedish moist snuff and myocardial infarction among men. | Q34378977 | ||
| Mortality from cancer in relation to smoking: 50 years observations on British doctors | Q34387787 | ||
| Oral cancer and precancerous lesions | Q34525597 | ||
| Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study | Q34627885 | ||
| Cancer and mortality among users and nonusers of snus. | Q34769895 | ||
| Is Swedish snus associated with smoking initiation or smoking cessation? | Q35539609 | ||
| Pharmacokinetics and pharmacodynamics of moist snuff in humans | Q35565115 | ||
| Smokeless tobacco use: harm reduction or induction approach? | Q35650428 | ||
| Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms | Q35816208 | ||
| Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? | Q35824475 | ||
| The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. | Q35901006 | ||
| Smokeless tobacco and oral cancer: a review of the risks and determinants | Q35911342 | ||
| Use of alcohol, tobacco and coffee, and risk of pancreatic cancer. | Q36048223 | ||
| A measure of nicotine dependence for smokeless tobacco users | Q36116942 | ||
| Alcohol and pancreatic cancer | Q36213155 | ||
| Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study | Q36408196 | ||
| Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. | Q36860026 | ||
| Role of snus in initiation and cessation of tobacco smoking in Sweden. | Q36930343 | ||
| Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction | Q37005348 | ||
| Does Smokeless Tobacco Cause Hypertension? | Q40435947 | ||
| Regular smokeless tobacco use is not a reliable predictor of smoking onset when psychosocial predictors are included in the model | Q40563837 | ||
| Most smokeless tobacco use is not a causal gateway to cigarettes: using order of product use to evaluate causation in a national US sample | Q40573610 | ||
| Measuring dependence in smokeless tobacco users. | Q40981878 | ||
| Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey | Q41790174 | ||
| Smoking cessation with smokeless tobacco and group therapy: an open, randomized, controlled trial | Q42664431 | ||
| Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden | Q43768385 | ||
| Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: findings from the Japan collaborative cohort study for evaluation of cancer risk | Q44062501 | ||
| Cardiovascular risk factors in young snuff-users and cigarette smokers | Q44483670 | ||
| Abnormal glucose metabolism and pancreatic cancer mortality | Q44511450 | ||
| Forearm endothelial response in smokeless tobacco users compared with cigarette smokers and nonusers of tobacco | Q44551299 | ||
| Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience | Q44575920 | ||
| Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market | Q45005233 | ||
| Oral leukoplakia status six weeks after cessation of smokeless tobacco use. | Q45142747 | ||
| The development of tobacco use in adolescence among "snus starters" and "cigarette starters": an analysis of the Swedish "BROMS" cohort. | Q45169874 | ||
| Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans | Q45336133 | ||
| Use of propensity score matching in evaluating smokeless tobacco as a gateway to smoking | Q46078196 | ||
| Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products | Q46119399 | ||
| Snuff dipping and oral cancer among women in the southern United States | Q46146520 | ||
| Smokeless tobacco use and health effects among baseball players | Q46203623 | ||
| Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines | Q46261442 | ||
| Use of smokeless tobacco is a risk factor for cigarette smoking | Q46867033 | ||
| Measuring nicotine dependence among smokeless tobacco users | Q46874297 | ||
| Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). | Q47780630 | ||
| Evolving patterns of tobacco use in northern Sweden | Q47901529 | ||
| A pilot study of smokeless tobacco in smoking cessation | Q48585584 | ||
| Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. | Q50876697 | ||
| Cigarette smoking, oral moist snuff use and glucose intolerance. | Q51554360 | ||
| Smoking cessation among daily smokers, aged 45-69 years: a longitudinal study in Malmö, Sweden. | Q52280754 | ||
| Snus: part of the problem or part of the solution? | Q52282756 | ||
| Characteristics of smokeless tobacco users seeking treatment. | Q52895695 | ||
| Smokeless tobacco use and risk of cancer of the pancreas and other organs. | Q53361790 | ||
| Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada. | Q53399554 | ||
| Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep's clothing? | Q56836070 | ||
| Smokeless Tobacco and the Risk of Stroke | Q57011244 | ||
| Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men | Q57011306 | ||
| Chronic Disease Mortality in a Cohort of Smokeless Tobacco Users | Q60692487 | ||
| Association between metabolic effects and tobacco use in 60-year-old Swedish men | Q61458244 | ||
| Evidence That Smokeless Tobacco Use Is a Gateway for Smoking Initiation in Young Adult Males | Q61693233 | ||
| Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. | Q64969882 | ||
| Hemodynamic effects of the use of oral snuff | Q67574363 | ||
| Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum | Q68433728 | ||
| Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study | Q72250137 | ||
| Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men | Q73218084 | ||
| Smokeless tobacco as a possible risk factor for stroke in men: a nested case-control study | Q73455539 | ||
| Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden | Q74404962 | ||
| Oral snuff impairs endothelial function in healthy snuff users | Q75827554 | ||
| Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users | Q77500163 | ||
| Impact of smokeless tobacco use on smoking in northern Sweden | Q78797587 | ||
| Re: Foulds and Ramstrom: Cancer Causes and Control 17: 227-228 (2006) and Henley et al., Cancer Causes and Control 16: 347-358 (2005). How smokeless tobacco can cause lung cancer | Q79750202 | ||
| The burden of mortality from smoking: comparing Sweden with other countries in the European Union | Q79902099 | ||
| The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking | Q80793120 | ||
| Smokeless tobacco and coronary heart disease: a 12-year follow-up study | Q81003436 | ||
| The decline of smoking in northern Sweden | Q81022858 | ||
| Possible carcinogenicity of smokeless tobacco | Q81312520 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | harm reduction | Q1458711 |
| P304 | page(s) | 197-211 | |
| P577 | publication date | 2009-09-29 | |
| P1433 | published in | Regulatory Toxicology and Pharmacology | Q2138805 |
| P1476 | title | An epidemiologic review of smokeless tobacco health effects and harm reduction potential | |
| P478 | volume | 56 |
| Q35225733 | A systematic review of transitions between cigarette and smokeless tobacco product use in the United States |
| Q39002723 | Association between iq'mik smokeless tobacco use and cardiometabolic risk profile among Yup'ik Alaska Native people |
| Q41873870 | Clinical and biochemical studies support smokeless tobacco's carcinogenic potential in the human oral cavity |
| Q39985541 | Exposure and response to current text-only smokeless tobacco health warnings among smokeless tobacco users aged ≥18years, United States, 2012-2013. |
| Q33839529 | Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cells |
| Q39696192 | Health, masculinity and smokeless tobacco use among college-aged men. |
| Q44909988 | Patterns of snus and cigarette use: a study of Norwegian men followed from age 16 to 19. |
| Q40565983 | Patterns of youth tobacco and polytobacco usage: The shift to alternative tobacco products. |
| Q37412909 | Predictors and patterns of cigarette and smokeless tobacco use among adolescents in 32 countries, 2007-2011. |
| Q90348431 | Real-World Evidence of Differences in Biomarkers of Exposure to Select Harmful and Potentially Harmful Constituents and Biomarkers of Potential Harm between Adult E-Vapor Users and Adult Cigarette Smokers |
| Q38635600 | Relationships Among Chewing Tobacco, Cigarette Smoking, and Chronic Health Conditions in Males 18-44 Years of Age. |
| Q38727366 | Shammah (Smokeless Tobacco) and Public Health |
| Q92812161 | Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures |
| Q37821539 | Summary of the epidemiological evidence relating snus to health. |
| Q35112234 | The development and psychometric evaluation of the Smokeless Tobacco Expectancies Scale (STES). |
| Q35978839 | The in vitro toxicology of Swedish snus |
| Q40402395 | Tobacco Use and Cancer Risk in the Agricultural Health Study |
| Q34361356 | Toxicology of smokeless tobacco: implications for immune, reproductive, and cardiovascular systems |
| Q39589052 | Trends in the use of smokeless tobacco in United States, 2000-2010. |
| Q34101084 | Who is using snus? - Time trends, socioeconomic and geographic characteristics of snus users in the ageing Swedish population |
Search more.